# FDA 483 - OrBion Pharmaceuticals Private Limited - September 08, 2023

Source: https://www.globalkeysolutions.net/records/483/orbion-pharmaceuticals-private-limited/b5f7d05a-7dad-40db-95aa-7bec1c6cb422

> FDA 483 for OrBion Pharmaceuticals Private Limited on September 08, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: OrBion Pharmaceuticals Private Limited
- Inspection Date: 2023-09-08
- Product Type: drugs
- Office Name: Office of Biological Products Operations - Division I

## Related Documents

- [483 - 2025-10-27](https://www.globalkeysolutions.net/records/483/orbion-pharmaceuticals-private-limited/c77d5f8a-9fe4-4f3a-9420-8cb38c1c0df4)
- [483 - 2023-09-08](https://www.globalkeysolutions.net/records/483/orbion-pharmaceuticals-private-limited/fde677e5-f9fb-4cc6-83d7-66cd8209d07b)

## Related Officers

- [Investigator ](https://www.globalkeysolutions.net/people/nicole-e-knowlton/8e65400f-249f-45fe-96fc-cb00fec6ae39)
- [Lillian S. Wu](https://www.globalkeysolutions.net/people/lillian-s-wu/b1f6643c-ac01-43e5-8ce2-e6f4fdba9d35)

Company: https://www.globalkeysolutions.net/companies/orbion-pharmaceuticals-private-limited/1cdc049d-587c-4283-8d5c-8604cff032c9

Office: https://www.globalkeysolutions.net/offices/office-of-biological-products-operations-division-i/49c53dac-7724-4c8c-8708-4f5779ea69c1